Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FT218 (once-nightly sodium oxybate) in narcolepsy
NCT04451668Phase 3Completed
- Sponsor
- Avadel Pharmaceuticals
- Start
- Jun 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules, Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of AV001 in narcolepsy, sponsored by Avadel Pharmaceuticals. Started Jun 2020; status: completed.
02
Drugs
AV001
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT04451668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451668.